Next-Gen Immunotherapy: Trispecific Antibodies Show 260x Potency Over Traditional Treatments
March 20, 2025 10:24 ET
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Trispecific Antibodies Clinical Trials, Fast Track Status, Technology Platforms & Market Opportunity Outlook 2025" report has been added to ...
Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast to 2034: Japan Leads Interleukin-2 Market Growth, With NSCLC & Atopic Dermatitis Driving Demand
March 20, 2025 08:14 ET
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...
Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
March 13, 2025 16:15 ET
|
Candel Therapeutics
Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, localized prostate cancerRecently announced positive final...
Allogeneic CAR-T Cell Patent Landscape and Forecast Report 2024-2032, Profiles of Artiva Biotherapeutics, Poseida Therapeutics, Nanjing Beiheng Biological Technology, NantCell, GC Cell, BMS, Compugen
March 13, 2025 11:02 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Allogeneic CAR-T Cell Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global allogenic...
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030
March 12, 2025 11:50 ET
|
Research and Markets
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Complement C4 Antibody Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
March 10, 2025 08:01 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., March 10, 2025 (GLOBE NEWSWIRE) -- Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral...
Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform
March 10, 2025 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032: Identify Emerging Therapeutic Targets and Assess the Competitive Landscape
March 06, 2025 11:00 ET
|
Research and Markets
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
March 05, 2025 12:15 ET
|
Siren Biotechnology, Inc.
Siren Biotechnology expands Clinical and Scientific Advisory Board with key industry leaders
Breast Cancer Drugs Market Size is Projected to Reach USD 80.34 Billion by 2033, Growing at a CAGR of 8.90%: Straits Research
March 04, 2025 09:50 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...